About this episode:
In this podcast, Dr Penny Heaton, Global Head of the Johnson and Johnson Office of the Chief Medical Officer, discusses: 

• J&J’s approach to patient centricity across the enterprise
• Her thoughts on balancing balancing safety and risk/benefit ratios with more engaged patients and more complex science
• Moving risk benefit assessments earlier into clinical development and the necessary change management
• Incorporating multiple streams of data for the purpose of creating medicines that truly address patient needs in the real world

For more information, go to PatientsasPartnersConference.com.

In this podcast, Nicole Murphy, EVP and Head of Pharmaceutical Operations & Technology at Biogen, discusses:

• Cross-functional collaboration to deliver value
• How Biogen is using AI to enhance innovation
• Supply chain simplification
• Biogen's partnership philosophy as it relates to drug delivery
• Their recent $2 billion manufacturing investment in the Research Triangle Park
• And Biogen's acquisition of Alcyone Therapeutics 

It's an enlightening look into what real leadership in drug delivery, manufacturing and supply chain management looks like. 

For more information, go to Drug-Delivery.org.

In this podcast, Kate Woda, Conference Director of the Immuno-Oncology 360° Summit, discusses what attendees can expect at the 12th annual event, including key topic areas, session highlights, presenting companies and more.

For more information about the upcoming event, full agenda and speakers, visit IO360Summit.com.

This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with CMOs and advisory solutions firms about how CMOs can work with consultants and fractional talent to stay on budget while getting the expertise needed. Specifically:

• Different profiles of fractional consultants
• What to look for in a consultant and how to ensure alignment with the team
• Scoping the role of fractional talent and iterating as company needs evolve
• How to best work with firms representing fractional talent
• Advice for CMOs thinking about consulting

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.

About this podcast:
This podcast dives deep into the fundamentals of antibody-drug conjugate design, specifically focusing on the selection of targeting antibodies, cytotoxic drugs, and linkers. Presenter Dr Deepa Pakianathan highlights key strategies for constructing ADCs and the critical differentiating features that enhance therapeutic efficacy and safety. 

For more information, go to IO360summit.com.

About this podcast:
This podcast comes from the 2025 Patients as Partners in Clinical Research conference. 

This panel discussion demonstrates how patient advocates are bridging the divide at the site level to improve patient representation in clinical trials. More specifically, this podcast focuses on: 

• Strategies for overcoming limited resources and lack of infrastructure, which can hinder inclusive clinical trial participation
• Successful models for empowering local leaders and leveraging community-based networks to increase participation
• Evaluating the impact of outreach and engagement efforts on enrollment representation and overall care equity
• And more

For more information, go to PatientsAsPartnersConference.com.

About this podcast: 
Liz Thompson, Global Development Leader, Senior Clinical Development Scientist at Roche, presented how the organization had delivered a single, cohesive protocol amendment categorization process to reduce the number of amendments and create a continuous improvement strategy, all to speed up timelines and reduce costs. This presentation comes from the September 2025 DPHARM: Disruptive Innovations to Modernize Clinical Research program. 

More specifically, Ms Thompson discusses how Roche is: 

• Leveraging historical amendment data to enable study teams to understand why protocols are being amended
• Utilizing a visual data science platform to generate insights from data to make better data-driven decisions
• Applying retrospective learning into current protocols to curb the need for amendments
• Building in business value 

For more information, go to DPHARMconference.com.

About this podcast:
This session was recorded at the September 2025 CRAACO: Clinical Research as a Care Option conference.

Rural sites represent untapped potential for reaching a broader array of patients and providing them access to life-changing clinical trials, but existing clinical trial infrastructure does not set rural sites up for success. 

Funded through the Genentech Innovation Fund, Montana State University and Billings Clinic created a rural clinical research readiness toolkit for unaffiliated rural and frontier healthcare systems to empower them to meet clinical research demands without compromising local care delivery.

More specifically, this presentation covers the tools created to toolkit empowers sites to do clinical research, including:

• Interpretable workflow templates
• A workload calculator for staff capacity planning
• Patient safety indicators to support enrollment and retention
• EHR-based visualization methods to assist clinical decision-making when trial participants are also patients
• And more

For more information, go to theconferenceforum.org.

This podcast features a panel discussion from the 2025 Chief Medical Officer Summit 360° with biotech CMOs about how CMOs can support value creation in biotechs and how that is influenced buy the current biotech financial climate. Specifically:

• The importance of storytelling and leading thoughtfully
• Effective prioritization and execution towards the company narrative
• Balancing the team to be lean while avoiding the potential pitfalls of running lean
• Balancing the data collected to be interesting to investigators and important for the program to proceed
• Clinical data generation is better than preclinical dreams
• Strategically choosing a first indication and building sufficient scientific bridging to support subsequent indications

To learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.

In this podcast from the DPHARM 2024 archives, Biogen discussed how they used an AI-enabled software to detect cognitive impairment and Alzheimer’s disease neuropathology, based on voice, to provide access to patients  with a clinically validated cognitive assessment who might not otherwise have the foundation to start a conversation with their physician about their cognition. 

For more information, go to DPHARMconference.com